L Lisata Therapeutics
L
Chiusa
3.16 2.6
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
3.12
Massimo
3.17
Entrata | 1.3M -3M |
|---|---|
Vendite | 100K 100K |
Margine di Profitto | -2,954 |
Dipendenti | 21 |
Utili prossimi | 6 ago 2026 |
|---|
Capitalizzazione di Mercato | -16M 24M |
|---|---|
Apertura precedente | 0.56 |
Chiusura precedente | 3.16 |
Lisata Therapeutics Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Notizie correlate
Confronto tra pari
Modifica del prezzo
Lisata Therapeutics Previsione
Notizie finanziarie
Spese di vendita e di amministrazione
Utile prima delle imposte
Vendite
Utile operativo
$
Chi Siamo Lisata Therapeutics
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.